Titcomb Shawn 13D and 13G filings for ZyVersa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-13 3:11 pm Purchase | 2023-01-13 | 13G | ZyVersa Therapeutics, Inc. ZVSA | Titcomb Shawn | 2,499 9.630% | 2,499 (New Position) | Filing |